Challenges and solutions for the implementation of shared decision-making in breast reconstruction by Myckatyn, Terence M. et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2020 
Challenges and solutions for the implementation of shared 
decision-making in breast reconstruction 
Terence M. Myckatyn 
Rajiv P. Parikh 
Clara Lee 
Mary C. Politi 











































A 52-year-old woman presents with a new, left 2.0-cm 
invasive ductal carcinoma. She has a history of left duc-
tal carcinoma in situ treated with breast conservation 
therapy. Her breast remains indurated with predomi-
nantly superomedial volume loss, nipple-areolar distor-
tion, and malposition. The new breast cancer is located 
in the inferolateral quadrant. The left breast is estimated 
to weigh ~800 g and the right ~1,000 g. The patient is a 
nonsmoker, has a body mass index (BMI, kg/m2) of 32, 
travels 3 hours each way to see her plastic surgeon, and 
has had a laparotomy and left lower quadrant colostomy 
from a traumatic injury. Her surgical oncologist has rec-
ommended bilateral mastectomies. The patient requests 
immediate prepectoral implants following nipple-spar-
ing mastectomy based on a friend’s experience. You are 
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Background: Patient-centered care is a hallmark of quality in healthcare. It is 
defined as care that is respectful of, and responsive to, individual patient prefer-
ences, needs, and values, while ensuring patients are informed and engaged in the 
treatment decision-making process. 
Methods: We reviewed the literature and drew upon our own experiences to study 
the implementation of tools intended to facilitate shared decision-making in breast 
reconstruction. 
Results: For women with breast cancer, decision-making about breast reconstruc-
tion is often a challenging and perplexing process. The variety of choices avail-
able regarding timing and type of reconstruction and the unique individual patient 
and clinical treatment variables to consider can further complicate decisions. 
Accordingly, strategies to facilitate the decision-making process and enable patients 
and clinicians to make high-quality decisions about breast reconstruction are an 
essential component of comprehensive breast cancer care. Shared decision mak-
ing is one proposed model to support informed and preference-sensitive decision-
making in line with the principles of patient-centered care. Despite an emerging 
level of interest in shared decision making, there remains a lack of clarity regarding 
what the process involves and how to effectively implement it into clinical practice.
Conclusions: Thus, widespread adoption of shared decision making remains lack-
ing in clinical practice for women considering postmastectomy breast reconstruc-
tion. To address these gaps, this article reviews the principles of shared decision 
making, explores ways shared decision making can be utilized for patients who are 
candidates for breast reconstruction, and provides a practical overview to facilitate 
implementation of shared decision making into clinical practice. (Plast Reconstr 
Surg Glob Open 2020;8:e2645; doi: 10.1097/GOX.0000000000002645; Published online 
6 February 2020.)
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running behind in clinic this afternoon and still have 6 
other new patients to see in the next 2 hours.
THE ROLE OF SHARED DECISION-MAKING 
IN BREAST RECONSTRUCTION
Patients, physicians, administrators, insurance com-
panies, and policy makers are committed to supporting 
high-quality postmastectomy breast reconstruction that 
produces favorable outcomes with minimal complica-
tions. These individuals recognize the importance of these 
goals overall, but may differ in how they are prioritized. 
Shared decision-making (SDM) engages women and their 
plastic surgeons to consider whether, when, and how to 
reconstruct the breast following mastectomy. Patient deci-
sion aids (DAs) can provide a framework that supports 
the SDM process for women considering the option of 
postmastectomy breast reconstruction.1–5 In theory, SDM, 
is a necessary component of the preoperative interaction 
between plastic surgeons and their patients considering 
reconstruction. Indeed, many plastic surgeons report that 
they already engage in an SDM process, in spirit, if not by 
name. In practice, however, several barriers can derail a 
well-intentioned plastic surgeon from engaging in effec-
tive SDM.
In the case example above, immediate reconstruc-
tion, elevated BMI, and former radiation are all associated 
with increased reconstructive failure rates. Immediate, 
implant-based reconstruction is particularly problematic 
in the setting of radiation and obesity.6 Application of 
an evidence-based approach to this case favors delayed 
reconstruction following skin-sparing mastectomy with 
autologous flaps. Her previous history of abdominal 
surgery requires thigh-, buttock-, latissimus-, or lumbar-
based autologous flap options. These strategies stand in 
contrast, however, with the patient’s initial preference for 
direct-to-implant reconstruction immediately following 
nipple-sparing mastectomy.
SDM is ideally suited to this clinical situation. Although 
the outcomes of each reconstruction option might not be 
completely equivalent given the patient’s history and clini-
cal characteristics, several treatment choices are available 
to this patient. This patient may not fully understand the 
pros and cons of each option. Engaging the patient in 
a review of treatment options while exploring her pref-
erences can help the surgeon and patient arrive at an 
informed, preference-concordant decision. Ultimately, 
the patient’s individual risk factors and clinical character-
istics will need to be balanced with her preferences and 
goals to make a high-quality treatment decision.
FIVE STEPS OF SDM
The Agency for Healthcare Research and Quality pro-
poses the “SHARE” Approach to SDM based on 5 essential 
steps (Tables  1 and 2).7,8 These steps can be tailored to 
suit a particular patient encounter and represent a prac-
tical and efficient way to engage patients in SDM. Most 
patients prefer a collaborative approach over deferring 
treatment decisions to their clinician.12–14 In many cases, 
however, patients are aware of a power differential in the 
patient–physician relationship and may be reticent to 
initiate a 2-way conversation regarding breast reconstruc-
tion.15 For this reason, the plastic surgeon should begin 
the SDM process. For example, the surgeon can state “It is 
helpful for you to share what is important to you so we can 
make the best treatment together.” In the second stage 
of SDM, plastic surgeons describe reconstructive treat-
ment options and each option’s pros and cons. The third 
step of SDM involves assessing patients’ preferences and 
prioritizing and contextualizing those preferences in the 
setting of breast reconstruction. For example, the relative 
importance of breast aesthetics or the degree to which a 
women’s perceived identity is defined by them, fear of sur-
gery or the medical community in general, socioeconomic 
concerns, impact on occupation or family, and travel dis-
tance can impact a patient’s approach to decision-making. 
The relative merits of available reconstruction options are 
then juxtaposed with an individual patient’s preferences 
to reach a decision in the fourth step of SDM. The fifth 
and final step of Agency for Healthcare Research and 
Quality’s SHARE approach is to consider next steps that 
facilitate implementing the decision. For breast recon-
struction, this can involve coordinating with the surgical 
and potential medical and radiation oncology providers. 
Furthermore, it may involve giving patients the appro-
priate amount of time to consider their options, discuss 
with family/friends/other patients, and weigh any social 
and economic influences on the decision (ie, support at 
home, time off work, etc.).
CHALLENGES AND SOLUTIONS FOR 
IMPLEMENTING SDM
Although an SDM approach to breast reconstruction is 
favored by most plastic surgeons in theory, several barriers 
can limit its implementation in practice.
Finding Time to Engage in SDM
Foremost among the barriers to SDM is allotting 
adequate time to the SDM process: (1) time to explore 
reconstructive options and to make sure that patients 
understand the discussion; (2) time to understand a 
patient’s preferences; (3) time to review information or 
a patient’s initial thoughts in the face of a condensed 
runway from consultation to surgery, an advanced tumor 
that mandates rapid intervention, and busy schedules. 
We have previously shown that implementation of a high-
quality DA before a face-to-face visit can improve breast 
reconstruction quality by reducing knowledge gaps with-
out prolonging length of visit.16 Patients can use a DA at 
home, where there can be more time and family support 
Table 1. SHARE Approach to SDM*
Step Description
1 Seek patient’s participation
2 Help patient explore and compare treatment options
3 Assess patient values and preferences
4 Reach a decision with the patient
5 Evaluate patient’s decision
*The Agency for Healthcare Research and Quality SHARE Approach to SDM.9
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to review new, complex information, or in a waiting room 
or clinic room before the start of a consultation for those 
without Internet access or those preferring to review the 
information on-site. For the surgeon, this patient can be 
better prepared with evidence-based information and 
some initially formed preferences before the conversation 
with the surgeon. Alternatively, a DA can be used to rein-
force physician–patient communication and potentially 
diffuse a time-pressured interaction by administering it in 
the postconsultation phase.17 Next, it is imperative that the 
plastic surgeons spend adequate time with their patients 
to develop trust and ensure that they have a handle on the 
medical and social variables that may impact breast recon-
struction. Instructional videos as used in some patient 
education materials,18 initial discussions with an experi-
enced nurse, nurse practitioner, or PA, and informational 
brochures can supplement the plastic surgery clinic expe-
rience and provide support using an interprofessional 
team-based approach to SDM.19
Quality of Information That Supports SDM
The information plastic surgeons use to define vari-
ous reconstructive options may also represent a barrier 
to SDM. The quality and level of evidence to describe 
clinical and patient-reported outcomes has improved, 
but continues to have limitations. A DA can implement 
risk prediction into the SDM process to address some of 
these evidence limitations. As an example, a DA we previ-
ously developed and evaluated, the Breast Reconstruction 
Education and Support Tool (BREASTChoice), combines 
a risk prediction model derived from analysis of 17,000 
patients undergoing surgical treatment for breast cancer 
and uses clear, standardized visual tools to communicate 
risk.20 Reported risks are derived from a wide breadth of 
providers, patients, and care settings to improve their gen-
eralizability. By inserting evidence-based clear risk predic-
tion into the SDM process, consistent information can be 
communicated to patients. Regardless of the exact con-
struct of the DA, incorporation of a risk prediction model 
that accounts for patient’s clinical characteristics (eg, 
BMI, smoking status, hypertension, lung disease, previous 
radiation therapy, diabetes, medications) and communi-
cates it clearly can improve patient understanding of the 
likelihood of complications with reconstruction options.
Of equal importance is the availability of information 
that a particular patient perceives as relevant to them. The 
Surveillance, Epidemiology, and End Results database has 
been effectively leveraged to identify barriers to recon-
struction including overall access and availability of infor-
mation, most prominently for women from racial and 
socioeconomically marginalized groups.21–23 Indeed, we 
have noted that women often perceive race- or age-related 
biases with information sharing.13 Patient materials need 
to include images that represent the breadth of skin tones, 
Table 2. Challenges and Solutions with the SHARE Approach to SDM
Challenge Solution
Patient reticent to engage in SDM. Identify reasons for reluctance such as lack of awareness of SDM or power dynamics. Involve 
patient in SDM to the degree they are comfortable. Ask patients about their preferences 
and check to make sure the treatment plan aligns with those preferences, even if the 
patient desires less engagement. Example language: “Every patient has different goals, 
and there is more than one choice of surgery. I want to make sure the surgery plan we 
choose is consistent with your goals of care.”
Patient having difficulty understanding 
treatment options.
Reduce the use of jargon. Create or obtain DAs and educational materials with an accessible 
reading level. When language is a barrier, use a translator to aid the discussion. Consider 
using pictures or photographs.
Patient is clinically a reasonable candidate for 
both autologous and implant options, but is 
having a hard time deciding between them.
Use a DA to help review patient preferences and goals. Specific concerns include time 
off work, number of surgeries, aesthetic outcome, concerns about implants, flap donor 
sites, or social and economic circumstances (eg, travel distance, family or job stressors). 
Incorporate these aspects into the discussion.
Despite the physician engaging the patient 
in SDM, exploring treatment options, and 
learning their preferences, the patient 
remains reluctant to make a decision about 
type of reconstruction.
Confirm that the patient is comfortable with their decisions leading up to the type of 
reconstruction (ie, mastectomy versus BCT versus screening imaging for prophylactic 
cases, or immediate versus delayed timing). Provide the patient a written summary of the 
SDM discussion. Ask them to make a second appointment before which they can consider 
their options.
Socioeconomic barriers including perceived 
time off work and anticipated out-of-pocket 
costs are a primary driver of the patient’s 
decision-making.
Inform the patient of when you anticipate that they can resume their day-to-day functions 
independently and get back to work. Provide referrals for financial resources to enable 
them to learn what their insurance deductible payments will be in advance. Provide 
information regarding financial assistance available through hospital- and community-
based charities.10,11 Resources to provide insurance coverage, help pay deductibles, cover 
medication costs, assist with travel or provide physical therapy may be available.11
The patient wants the surgeon to decide how 
to proceed.
Make a recommendation that is based on your understanding of the patient’s preferences to 
the extent that it is congruent with their risk profile. Outline how the recommendation is 
based on their characteristics and preferences so they may weigh in.
A patient with numerous major risk factors 
for complications (eg, smoking, obesity, 
diabetes, COPD) advocates for immediate 
implant breast reconstruction despite 
strong evidence to suggest she is at risk for 
complications.
This patient is at high risk for complications regardless of chosen reconstructive technique. 
Delayed reconstruction and use of an autologous flap in a radiated field are both 
strategies strongly supported by evidence, and personalized risk communication might 
facilitate an evidence-informed choice. In addition to delaying the reconstruction, help 
the patient with weight loss, smoking cessation, and/or blood sugar regulation, with set 
goals and follow-up appointments to discuss this plan and barriers to it. Consider referral 
to another plastic surgeon to reinforce the safest reconstructive approach.
BCT, breast conservation therapy; COPD, chronic obstructive pulmonary disease.
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BMIs, and ages of women who seek breast reconstruc-
tion.13,16 Breast reconstruction studies that have emerged 
to address quality of life, unique preferences and needs 
of potentially marginalized communities, and factors such 
as social support, time to heal, and travel distance can be 
extremely important for patients.24
Quality of Communication between Plastic Surgeons and 
Their Patients
How plastic surgeons and patients communicate with 
each other significantly impacts SDM and can be influ-
enced by dynamics of the doctor–patient relationship. 
This will vary from 1 case to the next, influenced by vari-
ables such as race, socioeconomic status, religion, health 
literacy and numeracy, age, and the length of the patient–
clinician relationship. The plastic surgeon must be aware 
of his/her own biases and the perception of a power 
imbalance that a patient may have when interacting with 
their surgeon. These factors impact the physician–patient 
interaction, possibly impeding a patient’s willingness or 
confidence to openly communicate her values and pref-
erences. Fortunately, several strategies can be employed 
to optimize communication. First, the plastic surgeon 
must recognize that barriers to communication may exist 
and not make assumptions about whether this is the case 
based on a particular patient’s profile. The plastic surgeon 
can ask open-ended questions and avoid medical jargon. 
Information exchange between patients and their plas-
tic surgeons can occur despite potential barriers to com-
munication with the implementation of a clinical DA. To 
broaden the generalizability of a DA, it is critical that they 
be written with broadly accessible language; standards sug-
gest a seventh-grade reading level or below.25 The plastic 
surgeon can modulate the level of complexity discussed 
thereafter, taking great care to be understandable on 
the one hand, but not condescending on the other. Data 
regarding risks can be presented as percentages and pro-
portions to facilitate patient understanding and the sur-
geon can seek to confirm a patient’s understanding using 
the teach-back technique (“tell me your understanding 
of what we just talked about”). All of these strategies are 
aimed at improving physician–patient communication.
Precision of Medical Information Used to Predict Risk
The quality of research that generates the data used 
to inform risk prediction algorithms with postmastectomy 
breast reconstruction is critically important. However, 
these algorithms are only accurate if complete and accu-
rate data for a particular patient are entered. Incomplete 
or inaccurate data can generate false assessments of risk 
prediction that can have more negative repercussions 
than using no risk prediction model at all. Manual data 
entry is an option, but this can be both resource and time 
intensive, and a clear barrier to broad adoption of a clini-
cal DA. One solution is to auto-populate the risk predic-
tion model algorithm through customized programming 
of the electronic medical record. This approach also 
serves to integrate the clinical DA into the patient medical 
record and can serve to provide a dynamic risk assessment 
as a patient’s circumstances change (ie, quit smoking, lost 
weight, now require radiation therapy).
A Fluid Approach to Accommodate Evolving Oncologic Care 
and Complications
Critical pieces of information that may impact deci-
sion-making for reconstructing a newly diagnosed breast 
cancer are often unavailable when a patient first meets 
their plastic surgeon. Information on margins, tumors 
markers, lymph node status, distant metastases, additional 
imaging, and genomic and genetic testing is usually pend-
ing but can have profound impact on the overall multidis-
ciplinary management strategy. Occasionally, the plastic 
surgeon is required to react to circumstances not necessar-
ily anticipated during the initial consultation and alter the 
reconstruction conversation. For example, reexcision of 
the skin envelope due to positive margins may expose the 
originally placed immediate implant and mandate conver-
sion to tissue expander or an autologous flap. It is criti-
cal that the surgical oncologist be included in decisions 
throughout the SDM process. Complications that develop 
over time will also affect, sometimes dramatically, the 
initially prescribed treatment strategy. Optimizing strate-
gies to treat and prevent the recurrence of breast cancer 
will always be the priority. This dynamic process requires 
a fluid and flexible approach to SDM. For example, an 
implant-based reconstruction may have been favored by 
the patient and a reasonable option based on risk assess-
ment at the outset; however, a compromised skin envelope 
due to an unforeseen explantation or unexpected need 
for radiotherapy will typically trigger a change of plan, 
whereby the autologous flap is now the favored option. 
Discussing this openly with the patient so she can prepare 
for possible outcomes is paramount to the SDM process 
and a patient-centered approach to care.
Ideally, the concept of reconstruction is introduced by 
the breast surgeon/surgical oncologist who needs to have a 
working understanding of the procedures, their risks, and 
how these are scheduled around other oncologic interven-
tions. A surgical oncologist sensitive to the evidence that 
favors 1 reconstruction over another based on factors such 
as stage, likelihood or radiation, and breast size may pre-
emptively refer the patient to a plastic surgeon capable 
of offering the most clinically appropriate options. In our 
practice, we have engaged in SDM and administered our 
DA between the surgical oncology and plastic surgery visits. 
However, we have encountered rare circumstances where 
the plastic surgeon is seen before the surgical oncologist. 
This most commonly occurs when a patient has had their 
original workup and made the decision to have a mas-
tectomy with 1 oncologist, but then has sought a second 
opinion at our institution. To expedite scheduling and 
intervention, the plastic surgeon may be seen before the 
surgical oncologist. As such, not only the clinical circum-
stances that inform it but also the timing of its implementa-
tion needs to be fluid and adaptable in the SDM process.
To accommodate the dynamic breast reconstruc-
tion cycle of care, a malleable approach to SDM that is 
responsive to evolving circumstances and relevant patient 
data is required. As such, plastic surgeons need to remain 
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committed to the SDM process through all of their patient 
interactions. They need to have the expertise and knowl-
edge to recognize what procedures best suit a particu-
lar patient at a given time and have the ability to offer 
a breadth of reconstructive options that, based on avail-
able evidence, would be most appropriate for the patient. 
If unable to offer a particular indicated procedure, they 
must have the insight to refer the patient on to a plastic 
surgeon who does offer a particular indicated procedure 
for the good of the patient. Engagement in SDM through-
out the course of breast reconstruction requires patience, 
tenacity, time, insight, technical expertise, and wisdom.
SDM and Scope of Practice
Several practical considerations may temper a plastic 
surgeon’s enthusiasm for engaging in SDM or using a DA. 
One practical consideration is that some plastic surgeons 
may not offer all available reconstructive techniques. For 
example, not all plastic surgeons offer autologous flap 
reconstructions that involve microsurgery and not all 
plastic surgeons offer prepectoral breast reconstruction 
techniques despite increasing evidence to support this 
approach.26–28 A surgeon may be reluctant to engage in a 
SDM process, or utilize a DA, that they are aware is likely to 
suggest a particular procedure that they do not offer. This 
reluctance may be borne of several factors. A plastic surgeon 
may not have received training with a particular technique 
or performs it so infrequently that they are uncomfortable 
with it. Furthermore, the expenditure of resources required 
to perform some techniques in particular may not be war-
ranted in other practices whose infrastructure focuses on 
the performance of other types of procedures. In some 
health-care systems, access to the operating room is limited 
and may deter plastic surgeons from offering microvascu-
lar breast reconstructions and encourage them to offer 
reconstructive procedures that take less time to perform 
or that can be more expeditiously scheduled to accom-
modate immediate postmastectomy breast reconstruction. 
Similarly, institutional or system-based factors may penalize 
or discourage providers from utilizing an acellular dermal 
matrix in breast reconstruction (a key component of pre-
pectoral reconstruction techniques).
There are several strategies that can improve the gen-
eralizability of the SDM process and DA tools in breast 
reconstruction for all plastic surgeons who offer breast 
reconstruction. In most cases, there are several reasonable 
options for reconstructing a breast following mastectomy. 
It is critical that the SDM process and accompanying deci-
sion support tools include all of these options so long as 
they can be supported by evidence. By expanding the 
scope of reasonable reconstructive options for a particu-
lar patient, the SDM approach becomes accessible to a 
broader cohort of practitioners. As plastic surgeons, we 
cannot dismiss both the science and art of our specialty. 
The success of a reconstruction can vary based on subtle 
nuances of technique and approach, derived from years of 
a surgeon’s experience, that are not identified by analysis 
of large datasets. The value of evidence-based medicine 
cannot be denied, but neither should the value of a par-
ticular plastic surgeon’s experience.
In some cases, patients will be confronted with very few 
reasonable reconstructive options. Under these circum-
stances, it is imperative that the plastic surgeon be able 
to identify these cases and counsel patients appropriately. 
The SDM process retains value in these cases as it can sup-
port a difficult decision to perform a potentially involved 
surgical procedure or justify referral to another plastic sur-
geon specialist. Barriers to referral from 1 plastic surgeon 
to another need to be overcome to ensure full engagement 
in the SDM process and minimize delays in treatment or 
performance of unnecessary procedures that are unlikely 
to work. A plastic surgeon who does not commonly per-
form microsurgery, for example, may refer their patient 
for a stacked perforator flap to a surgeon proficient in 
these techniques. At the same time, a complex postrecon-
structive asymmetry in a patient who has voiced some dis-
satisfaction with their outcome may be best served with a 
referral to another plastic surgeon experienced in breast 
reconstruction to reinforce the complexities of a particular 
patient’s circumstances, limitations of available corrective 
techniques, and to provide a second opinion on what are 
realistic expectations. The referring plastic surgeon needs 
to feel comfortable that they can send their patient, with 
whom they have developed a trusting relationship, to some-
one who will continue to provide the compassionate care 
that has been provided to that point. The accepting plastic 
surgeon needs to make time to see these referrals, com-
mend the referring plastic surgeon for making decisions 
that most benefit the patient, and refer the patient back 
to the original plastic surgeon for additional procedures if 
this is the preference of the referring plastic surgeon.
Ensuring that the breadth of breast reconstructive 
options is available to patients in the future also depends 
on the quality of breast reconstruction education offered 
by residency training programs. Most plastic surgeons will 
perform at least some breast reconstruction during their 
careers and the vast majority will not do fellowship train-
ing in breast reconstruction. Plastic surgeons who can 
confidently offer the breadth of breast reconstruction 
options either themselves, or via a partner, are more likely 
to engage in the SDM process.
CONCLUSIONS
SDM is an essential part of patient-centered care for 
women with breast cancer. In this article, we reviewed the 
principles of SDM and delineated the challenges, and 
potential solutions to these challenges, of implementing 
the SDM process into routine clinical care. As we strive to 
improve the quality of care provided to women pursuing 
breast reconstruction, it is our hope that the strategies out-
lined herein provide a practical guideline for plastic sur-
geons aiming to implement SDM in their clinical practices.
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